ArticleCureus2025
The Role of Hematological Parameters in Critically Ill Patients: Mortality Prediction in Elderly Intensive Care Unit Patients.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07332052 (Comparison of Parameters That Can be Used to Predict Frailty in Elderly Femur Fracture Patients.), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Comparison of Parameters That Can be Used to Predict Frailty in Elderly Femur Fracture Patients.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Elderly patients constitute a high-risk population in intensive care units (ICUs) due to multiple comorbidities, frailty, and limited physiological reserves. Despite advances in intensive care, mortality rates remain significantly high in this demographic. Identifying reliable predictors of mortality is crucial for early intervention and improved clinical outcomes. Hematological parameters, such as red cell distribution width (RDW), platelet-related measurements (including platelet count, mean platelet volume [MPV], and platelet distribution width [PDW]), and inflammatory markers like procalcitonin (PCT), have emerged as potential prognostic indicators. However, their predictive value in critically ill elderly patients remains controversial. Aims This study aims to determine whether hematological parameters, including RDW, platelet-related indices (platelet count, MPV, and PDW), and inflammatory markers such as PCT, can predict mortality in elderly patients admitted to ICUs. By establishing their prognostic significance, we seek to enhance early risk stratification and improve clinical decision-making. Methods A retrospective observational study was conducted on 238 patients aged 65 years and older who were admitted to the ICU. Laboratory values, demographic data, and clinical severity scores were analyzed. A receiver operating characteristic (ROC) curve analysis and logistic regression analysis were performed to assess the predictive value of hematological markers in relation to 39-day mortality. Results Among the study population, mortality occurred in 87 patients (36.6%), highlighting the high-risk nature of the geriatric intensive care cohort. RDW, PDW, MPV, and PCT levels were significantly higher in patients who did not survive (p < 0.0001). The ROC curve analysis identified PCT (area under the curve [AUC]: 0.925, p < 0.0001) and urea (AUC: 0.767, p < 0.0001) as the strongest classifiers of mortality. Logistic regression analysis confirmed PCT (odds ratio [OR]: 1.410, p < 0.0001) and PDW (OR: 1.427, p = 0.013) as independent mortality predictors. Conclusions Hematological parameters, particularly RDW, PDW, MPV, and PCT, are strong predictors of mortality in elderly patients in ICUs. These findings emphasize the role of systemic inflammation and coagulation in clinical outcomes within the intensive care setting. Integrating these parameters into clinical risk assessment models may improve early mortality prediction and allow for more targeted management strategies, ultimately improving survival in critically ill elderly patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.